Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
SPRYCompany Name
ARS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQARS PHARMACEUTICALS INC - Price to Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SPRY - P/FCF Historical data
| Date | Free Cash Flow | Market Capitalization | Price to Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ -53.38M | $ 1.56B | 0 |
| 3/31/2025 | $ -21.05M | $ 1.19B | 0 |
| 12/31/2024 | $ 12.98M | $ 1.4B | 108.13 |
| 9/30/2024 | $ -46.03M | $ 1.37B | 0 |
| 6/30/2024 | $ -44.23M | $ 948.09M | 0 |
| 3/31/2024 | $ -53.61M | $ 852.68M | 0 |
| 12/31/2023 | $ -59.44M | $ 868.51M | 0 |
| 9/30/2023 | $ -30.25M | $ 329.27M | 0 |
| 6/30/2023 | $ -34.09M | $ 654.64M | 0 |
| 3/31/2023 | $ -32.82M | $ 740.19M | 0 |
Key Performance Insights, Last 5 Years
- ARS PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/FCF stands at 0.
- Over the past 5 years, ARS PHARMACEUTICALS INC's average P/FCF has been 108.13.
- The median P/FCF for ARS PHARMACEUTICALS INC during this period was 108.13
- ARS PHARMACEUTICALS INC reached its highest P/FCF over the past 5 years at 108.13.
- The lowest P/FCF recorded by ARS PHARMACEUTICALS INC in the same timeframe 108.13
ARS PHARMACEUTICALS INC's P/FCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/FCF Benchmarks
Similar metrics to P/FCF:
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
Definition of Price to Free Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].Market Cap / FCF
(=) P/FCF P/FCF for ARS PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 0 ] / FCF [ $ -18.99M ]
(=) P/FCF [ 0 ] SPRY - Price to Free Cash Flow, Last 5 years
108.13
Minimum
Dec 31, 2024
108.13
Maximum
Dec 31, 2024
108.13
Average
108.13
Median
P/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/FCF for companies in the Total Stock Market. The average P/FCF of the companies is 18.32 with a standard deviation of 12.94.
The following table provides additional summary stats:
P/FCF in the Market:
| filtered constituents | 2.23K |
|---|---|
| min | 0.06 |
| max | 60.45 |
| average | 18.32 |
| median | 14.76 |
| std | 12.94 |